BlackRock, Inc. 13D and 13G filings for Relay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Relay Therapeutics, Inc. RLAY |
BlackRock Inc. BLK |
10,308,012 6.100% |
-4,366,250 (-29.75%) |
Filing |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
BlackRock Inc. BLK |
14,674,262 8.800% |
5,100,839 (+53.28%) |
Filing |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
BlackRock Inc. BLK |
9,573,423 7.800% |
1,575,438 (+19.70%) |
Filing |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
BlackRock Inc. BLK |
7,997,985 6.600% |
2,004,372 (+33.44%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Relay Therapeutics, Inc. RLAY |
BlackRock Inc. BLK |
5,993,613 5.500% |
5,993,613 (New Position) |
Filing |